Curative Biotechnology, Inc.
CUBTD
$1.20
$0.109.09%
OTC PK
| 09/30/2025 | 03/31/2025 | 09/30/2024 | 06/30/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 487.30K | 258.90K | 435.10K | 407.70K | 373.80K |
| Depreciation & Amortization | 21.80K | 21.90K | 21.90K | 2.00K | 2.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 509.10K | 282.50K | 460.60K | 963.40K | 934.00K |
| Operating Income | -509.10K | -282.50K | -460.60K | -963.40K | -934.00K |
| Income Before Tax | -764.80K | -481.60K | -882.10K | -1.29M | -935.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -764.80K | -481.60K | -882.10K | -1.29M | -935.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -764.80K | -481.60K | -882.10K | -1.29M | -935.90K |
| EBIT | -509.10K | -282.50K | -460.60K | -963.40K | -934.00K |
| EBITDA | -487.00K | -260.60K | -437.60K | -961.40K | -933.90K |
| EPS Basic | -0.11 | -0.16 | -0.15 | 0.00 | -0.03 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.09 | 0.00 | 0.00 |
| EPS Diluted | -0.11 | -0.16 | -0.15 | 0.00 | -0.03 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.09 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 6.66M | 6.21M | 6.02M | 571.65M | 566.62M |
| Average Diluted Shares Outstanding | 6.66M | 6.21M | 6.02M | 571.65M | 566.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |